AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • March 13th, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
This Credit Agreement (this “Agreement”) is entered into between JOHN PAPPAJOHN (“Pappajohn”), PECORA AND COMPANY (“Pecora”) and NNJCA CAPITAL, LLC (“NNJCA”, and with Pappajohn and Pecora, collectively the “Lender”), and CANCER GENETICS, INC., a Delaware corporation (the “Company”), as of February 13, 2012, amending and restating in its entirety a Credit Agreement among Pappajohn, the Company and certain other parties dated as of December 21, 2011.
AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 13th, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
This Amendment (this “Amendment”), dated as of March 9, 2012, by and between Cancer Genetics, Inc., a Delaware corporation (the “Company”), and DAM Holdings, LLC (the “Lender”), amends that certain Credit Agreement, dated as of March 23, 2011, by and between the Company and the Lender (the “Credit Agreement”) and the Promissory Note issued pursuant to the Credit Agreement in the principal amount of $3,000,000 dated March 23, 2011 (the “Note”). To the extent not otherwise defined herein, the capitalized terms used herein shall have the meanings assigned to them in the Credit Agreement or the Note.
SEVENTH ADDENDUM TO CREDIT AGREEMENTCredit Agreement • March 13th, 2012 • Cancer Genetics, Inc • Services-medical laboratories
This Seventh Addendum to Credit Agreement (“Seventh Addendum”) is made this 15th day of February, 2012, between Wells Fargo Bank, National Association (“Bank”) and Cancer Genetics, Inc. (“Borrower”).
INTER-CREDITOR AGREEMENT CANCER GENETICS, INC.Inter-Creditor Agreement • March 13th, 2012 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
This inter-creditor agreement (this “Agreement”) is made as of this 13th day of February, 2012 between Cancer Genetics, Inc., a Delaware corporation (the “Borrower”), John Pappajohn (“Pappajohn”), DAM Holdings, LLC, a Wisconsin limited liability company (“DAM”), Pecora and Company (“Pecora”), NNJCA Capital, LLC (“NNJCA”) and Equity Dynamics, Inc., as agent (“EDI”).
